Glucose isomerase, gene, vector, engineering bacteria and application thereof
A technology of glucose isomerase and genetically engineered bacteria, applied in the direction of genetic engineering, isomerase, application, etc., to achieve the effect of high enzyme activity and excellent thermal stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Example 1: Gene synthesis of glucose isomerase
[0027] The glucose isomerase gene sequence was screened using the protein PDB database and NCBI database, and the glucose isomerase gene (GenBank accession no.WP_016329521.1) derived from Thermus oshimai was obtained. According to the amino acid sequence of the glucose isomerase, and codon optimization according to the codon preference of Escherichia coli, the nucleotide sequence of the glucose isomerase was synthesized by the conventional operation of genetic engineering, such as SEQ ID Shown in NO.2; the amino acid sequence encoding the enzyme is shown in SEQ ID NO.1. Add 6×his-tag tags at the end of the nucleic acid sequence, add restriction sites Xba I and Xho I at both ends, clone the gene into the Xba I and Xho I sites corresponding to pET28b(+), and obtain the recombinant expression plasmid pET28b / ToGI.
Embodiment 2
[0028] Embodiment 2: Transformation of recombinant plasmid and screening of recombinant bacteria
[0029] The recombinant expression plasmid pET28b / ToGI obtained in Example 1 was transformed into Escherichia coli BL21 (DE3) recipient bacteria, spread on an agar plate containing a final concentration of 50 μg / mL kanamycin, and cultured overnight at 37°C. On the second day, clones were randomly selected from the colonies grown on the plate, and the plasmids were extracted for identification by agarose gel electrophoresis to obtain genetically engineered bacteria containing the glucose isomerase gene.
Embodiment 3
[0030] Embodiment 3: Induced expression of recombinant engineering bacteria
[0031] LB liquid medium composition: tryptone 10g / L, yeast powder 5g / L, NaCl 10g / L, solvent is water, pH value is natural; LB solid medium is added 20g / L agar in LB liquid medium; 121℃ high pressure Sterilize for 20 minutes; add kanamycin at a final concentration of 50 μg / mL before use.
[0032] Inoculate the genetically engineered bacteria containing the glucose isomerase gene obtained in Example 2 into LB liquid medium containing a final concentration of 50 μg / mL kanamycin, and cultivate the OD at 37°C and 150r / min. 600 About 0.6-0.8 to obtain the seed solution; inoculate the seed solution with a volume concentration of 2% inoculum into fresh LB medium containing a final concentration of 50 μg / mL kanamycin, and cultivate OD at 37°C and 150r / min 600 To 0.6-0.8, add IPTG with a final concentration of 0.1mM to the culture medium, induce expression at 28°C for 10h, centrifuge at 8000r / min at 4°C for 1...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com